SurModics (SRDX) Reports Q4 EPS of $0.18

SurModics (NASDAQ: SRDX) reported Q4 EPS of $0.18, versus $0.26 reported last year. Revenue for the quarter came in at $20.1 million, versus $18.2 million reported last year.

Surmodics expects fiscal year 2018 revenue to range from $72.0 million to $75.0 million. The Company expects diluted loss in the range of $0.50 to $0.75 per share, which reflects the Company’s commitment to accelerate execution of its whole-product solutions strategy with increased research and development investments. Non-GAAP diluted loss is expected to be in the range of $0.16 to $0.41 per share.

For earnings history and earnings-related data on SurModics (SRDX) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth